PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1977 December; 70(12): 871–874.
PMCID: PMC1543529

The evidence justifying immunosuppression therapy in multiple sclerosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (659K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brendel W, Seifert J, Lob G. Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders. Proc R Soc Med. 1972 Jun;65(6):531–535. [PMC free article] [PubMed]
  • Frick E. Zur immunsuppressiven Behandlung der Multiplen Sklerose. Nervenarzt. 1976 Jul;47(7):424–428. [PubMed]
  • Jersild C, Dupont B, Fog T, Platz PJ, Svejgaard A. Histocompatibility determinants in multiple sclerosis. Transplant Rev. 1975;22:148–163. [PubMed]
  • Knight SC, Lance EM, Abbosh J, Munro A, O'Brien J. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol. 1975 Jul;21(1):23–31. [PubMed]
  • Lance EM, Kremer M, Abbosh J, Jones VE, Knight S, Medawar PB. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. Clin Exp Immunol. 1975 Jul;21(1):1–12. [PubMed]
  • McFarlin DE, Blank SE, Kibler RF. Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol. 1974 Aug;113(2):712–715. [PubMed]
  • Mertin J, Meade CJ. Relevance of fatty acids in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):67–71. [PubMed]
  • Millar JH, Zilkha KJ, Langman MJ, Wright HP, Smith AD, Belin J, Thompson RH. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973 Mar 31;1(5856):765–768. [PMC free article] [PubMed]
  • Paterson PY. Multiple sclerosis: an immunologic reassessment. J Chronic Dis. 1973 Mar;26(3):119–126. [PubMed]
  • Ring J, Seifert J, Anstwurm H, Frick E, Mertin J, Brass B, Backmund H, Lob G. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis. Postgrad Med J. 1976;52(5 Suppl):123–130. [PubMed]
  • Rose AS, Kuzma JW, Kurtzke JF, Namerow NS, Sibley WA, Tourtellotte WW. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report. Neurology. 1970 May;20(5):1–59. [PubMed]
  • Seland TP, Mc Pherson TA, Grace M, Lamoureux G, Blain JG. Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis. Neurology. 1974 Jan;24(1):34–40. [PubMed]
  • Sheremata W, Cosgrove JB, Eylar EH. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis. N Engl J Med. 1974 Jul 4;291(1):14–17. [PubMed]
  • Smeraldi E, Scorza-Smeraldi R. Interference between anti-HLA antibodies and chlorpromazine. Nature. 1976 Apr 8;260(5551):532–533. [PubMed]
  • Svejgaard A, Ryder LP. Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations. Lancet. 1976 Sep 11;2(7985):547–549. [PubMed]
  • Thompson EJ. Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects. Br Med Bull. 1977 Jan;33(1):28–33. [PubMed]
  • Wiśniewski HM. Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull. 1977 Jan;33(1):54–59. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press